InvestorsHub Logo
Followers 71
Posts 11465
Boards Moderated 0
Alias Born 12/25/2009

Re: None

Tuesday, 08/01/2017 8:10:39 AM

Tuesday, August 01, 2017 8:10:39 AM

Post# of 190
Cantor Fitzgerald Starts Neos Therapeutics (NEOS) at Overweight

July 31, 2017 4:05 PM EDT

Cantor Fitzgerald initiates coverage on Neos Therapeutics (NASDAQ: NEOS) with a Overweight rating and a price target of $20.00.

https://www.streetinsider.com/Analyst+Comments/Cantor+Fitzgerald+Starts+Neos+Therapeutics+(NEOS)+at+Overweight/13148515.html

NEOS